Bonus BioGroup Ltd. (TLV:BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 24.90
+0.20 (0.81%)
At close: Dec 4, 2025
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 290.81 million as of December 5, 2025. Its market cap has increased by 112.82% in one year.
Market Cap
290.81M
Enterprise Value
299.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
24.90
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 290.81M, an increase of 2,252.36%. That is a compound annual growth rate of 26.64%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 103.27B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.32B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 1.01B |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 653.92M |